×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

header-image

Catching Cancer with Low Dose CT Helps Drop Lung Cancer Deaths by 20 Percent in High Risk Individuals

September 14, 2015
Dr. Ella Kazerooni knows a thing or two about looking for lung cancer. As the chair of the American College of Radiology’s committee on lung cancer screening, she has been at the forefront of giving doctors the tools they need to diagnose high-risk patients early.
header-image

Ancestors of Billion-Year-Old Microbes Might Hold Clues to Evolution, Antibiotics, Cancer

August 09, 2015
The acidic bowels of Yellowstone’s hot springs, roiling subsea volcanic vents, and many other deadly and inhospitable places hide colonies of microorganisms that have for centuries eluded scientists. The microbes are now helping researchers shed light on the very beginning of life on Earth, and improve everything from gold extraction and sewage treatment to cancer drugs.
header-image

Shooting Disease with Silver Bullets: GE Ventures Leader Joins U.S. Precision Medicine Program

April 02, 2015
Oncologist Brian Druker has done something few cancer researchers aim for: he increased the number of people living with cancer.
In the 1990s, Dr. Druker, who does research at Oregon Health & Science University, was part of a Novartis team that helped develop Gleevec, a “miracle drug” that soundly defeated a previously deadly type of blood cancer called chronic myeloid leukemia, or CML.
header-image

Brinnon Garrett Mandel: Global Health Innovation at Work — A New Approach to Cancer Screening

Brinnon Garrett Mandel Jhpiego
September 16, 2014
Innovation is the buzzword of the decade. Touted by government officials, corporate and civic leaders and entrepreneurs, the word has become a stand-in for anything cutting edge or trend setting.
 

But for those of us working in the field of global health, innovation is the driving force behind transformational change that can propel the most promising solutions to the world’s relentless health challenges.
header-image

Fighting Cancer in Ethiopia

August 16, 2014

header-image

The Worst Brings Out the Best

Andy Von Eschenbach Samaritan Health Initiatives
June 25, 2014
The 20th Century was replete with natural and human disasters that caused society to devote itself at all costs to make the world a better place. Most noble among these efforts was our nation’s commitment to rid the world of the tragic disease called cancer.
By 1970, cancer was terrorizing almost every American family as it inflicted terrible suffering and for most patients an almost certain death sentence. Its solution was either unknown or, when known, associated with dire consequences. Cancer’s toll on society went beyond human suffering to threaten economic disaster.
header-image

OMG! Super-Resolution Microscope Shines Light on Superbugs, Cancer and Drug-Resistant Slime

March 11, 2014
Researchers call it the “OMG” microscope. They use the machine, whose proper name is DeltaVision OMX*, to study malaria parasites worming their way into red blood cells, see how the HIV virus jumps from a cell to cell, and look for weak spots in the defenses of dangerous superbugs like MRSA and drug-resistant slime.
header-image

International Women’s Day, a Chance for Change

Ambassador Sally G Cowal American Cancer Society
March 07, 2014
We celebrate International Women’s Day March 8. Originally, it was an event to promote equal political rights, including the right to vote, for women. As a Chicagoan I’m proud to say that one of the earliest Women’s Day observances was held in that city in 1908!
Today, although women have the right to vote almost everywhere, health inequalities and disparities between women in the developed and developing worlds – and between men and women in many countries and regions of the world – continue to exist.
header-image

Testing the Water: RainDance is Stalking Cancer Drop by Drop

March 03, 2014

RainDance Technologies is developing new “liquid biopsy” systems using tiny droplets separated by oil to analyze DNA. Researchers using the technology are evaluating its ability to identify whether the samples may contain cancer, viruses, pathogens and markers released by the immune system.

The new tools could allow doctors to test tumors and cancer cells with a simple needle prick. RainDance, which is based in Billerica, Mass, just received a new $16.5 million round of financing from a group of investors including GE’s venture capital arm, GE Ventures.

header-image

This Time It’s Personal: New High-Tech Weapons Take Close Aim at Cancer

February 04, 2014

Hardly a week goes by without news of cancer breakthroughs or promising new treatments. In December, for example, scientists at the Karolinska Institutet and Science for Life Laboratory in Stockholm found gene-coding regions possibly linked to cancer in parts of the DNA that were long considered gibberish.

Subscribe to Cancer